Mode
Text Size
Log in / Sign up

Can hydrogels improve drug delivery for treating anterior segment uveitis?

high confidence  ·  Last reviewed July 16, 2026

Anterior uveitis is inflammation of the front part of the eye, often treated with corticosteroid eye drops. However, conventional drops have low bioavailability due to rapid tear dilution and blinking, requiring frequent dosing. Hydrogels — water-swollen polymer networks — can overcome these barriers by providing sustained drug release, better eye surface retention, and improved tissue penetration. Research shows that hydrogel-based formulations can deliver drugs more effectively and even combine multiple therapeutic agents for synergistic effects.

What the research says

A 2023 study developed multifunctional hydrogel eye drops (DCFH) containing dexamethasone and cerium-based nanoparticles that scavenge reactive oxygen species. In a rabbit model of uveitis, these drops significantly reduced inflammation and suppressed inflammatory cytokines (TNF-α, IL-6, IL-17) better than standard solutions, thanks to improved ocular bioavailability and synergistic anti-inflammatory action 6. Another study tested dexamethasone-eluting contact lenses (Dex-Lens) made from hydrogel, which delivered drug for 7 days in rabbits and effectively treated anterior uveitis for 5 days, matching the efficacy of hourly dexamethasone drops 7. A 2025 review highlights that nanotechnology-driven approaches, including hydrogels, solve limitations of conventional eye drops such as poor penetration, short retention, and frequent administration 8. Additionally, a comprehensive review notes that hydrogels can be engineered as adhesive eye drops or thermosensitive gels to overcome ocular barriers like the corneal epithelium and blood-aqueous barrier, making them promising for anterior segment diseases including uveitis 1.

What to ask your doctor

  • Are hydrogel-based eye drops or contact lenses available for my type of uveitis?
  • Could a sustained-release formulation reduce how often I need to apply drops?
  • What are the potential side effects or risks of hydrogel drug delivery systems?
  • Are there any clinical trials testing hydrogel treatments for anterior uveitis that I might join?
  • How do hydrogel treatments compare with standard corticosteroid drops in terms of effectiveness and safety?

This question is drawn from common patient questions about Ophthalmology and answered using cited medical research. We do not provide individualized advice.